In addition, a published trial conducted by Yi-Long Wu [9] confirmed that sequence of paclitaxel followed by gefitinib was an appropriate treatment regimen for AdC patients with activating EGFR mutation, indicating that the sequence of chemotherapy plus EGFR-TKIs might improve their efficacy. This evidence concerns the gene EGFR and AIDS dementia complex.